SMARXT TISSUE-SPECIFIC Trademark

Trademark Overview


On Wednesday, July 7, 2021, a trademark application was filed for SMARXT TISSUE-SPECIFIC with the United States Patent and Trademark Office. The USPTO has given the SMARXT TISSUE-SPECIFIC trademark a serial number of 90816261. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, October 14, 2023. This trademark is owned by Immix Biopharma, Inc.. The SMARXT TISSUE-SPECIFIC trademark is filed in the Pharmaceutical Products category with the following description:

Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
smarxt tissue-specific

General Information


Serial Number90816261
Word MarkSMARXT TISSUE-SPECIFIC
Filing DateWednesday, July 7, 2021
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, October 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmix Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90064

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Saturday, October 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 14, 2023NON-FINAL ACTION E-MAILED
Saturday, October 14, 2023NON-FINAL ACTION WRITTEN
Thursday, November 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 10, 2022ASSIGNED TO LIE
Tuesday, September 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 27, 2022NON-FINAL ACTION E-MAILED
Sunday, March 27, 2022NON-FINAL ACTION WRITTEN
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 10, 2021NEW APPLICATION ENTERED